Sun Pharma Advanced Research Company Limited (NSE:SPARC)
212.50
+1.91 (0.91%)
Nov 12, 2026, 3:30 PM IST
NSE:SPARC Revenue
Sun Pharma Advanced Research Company had revenue of 300.30M INR in the quarter ending September 30, 2026, with 282.06% growth. This brings the company's total for the last twelve months to 19.32B, up 3,141.19% year-over-year. In the fiscal year ending March 31, 2026, Sun Pharma Advanced Research Company had annual revenue of 18.79B with 2,518.47% growth. That makes Sun Pharma Advanced Research Company the 17,279th largest company in the world by revenue and 939th in India.
Revenue (ttm)
19.32B
Revenue Growth
+3,141.19%
P/S Ratio
3.53
Revenue / Employee
69.23M
Employees
279
Market Cap
68.96B
Revenue by Geography
- India 380.49M 97.2%
- Outside India 11.00M 2.8%
Fiscal year ended Mar 31, 2026 See the full NSE:SPARC breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.79B | 18.07B | 2,518.47% |
| Mar 31, 2025 | 717.66M | -37.79M | -5.00% |
| Mar 31, 2024 | 755.45M | -1.63B | -68.36% |
| Mar 31, 2023 | 2.39B | 1.02B | 73.98% |
| Mar 31, 2022 | 1.37B | -1.16B | -45.74% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 52.13B |
| Akums Drugs and Pharmaceuticals | 48.29B |
| NATCO Pharma | 34.85B |
| Eris Lifesciences | 33.12B |
| Aarti Pharmalabs | 19.69B |
| Innova Captab | 17.49B |
| Solara Active Pharma Sciences | 15.35B |
| Orchid Pharma | 8.52B |
Sun Pharma Advanced Research Company News
- 10 days ago - Sun Pharma Advanced Research Company Quarterly report: Q2 2027 - Filings
- 3 months ago - Sun Pharma Advanced Research Company Quarterly report: Q1 2027 - Filings
- 4 months ago - Sparc to hold 21st AGM on August 10, 2026 via video conference - Business Upturn
- 5 months ago - Sun Pharma Advanced Research Company receives Rs 149.99 crore for warrant allotment - Business Upturn
- 5 months ago - 52-week high stocks today: Apollo Micro up 8.69%, NRB Bearings gains 5.28%, Angel One rises 2.11%; HFCL, SPARC and Timex hit fresh highs - Business Upturn
- 5 months ago - Sun Pharma Advanced Research partner receives FDA response on PDP-716 application - Business Upturn
- 5 months ago - Why are Sun Pharma Advanced shares up over 14% today? Explained - Business Upturn
- 5 months ago - Sun Pharma Advanced Research Company Quarterly report: Q4 2026 - Filings